» Articles » PMID: 22935699

Identification of an Estrogen-regulated Circadian Mechanism Necessary for Breast Acinar Morphogenesis

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2012 Sep 1
PMID 22935699
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Altered estrogen receptor α (ERA) signaling and altered circadian rhythms are both features of breast cancer. By using a method to entrain circadian oscillations in human cultured cells, we recently reported that the expression of key clock genes oscillates in a circadian fashion in ERA-positive breast epithelial cells but not in breast cancer cells, regardless of their ERA status. Moreover, we reported that ERA mRNA oscillates in a circadian fashion in ERA-positive breast epithelial cells, but not in ERA-positive breast cancer cells. By using ERA-positive HME1 breast epithelial cells, which can be both entrained in vitro and can form mammary gland-like acinar structures in three-dimensional (3D) culture, first we identified a circuit encompassing ERA and an estrogen-regulated loop consisting of two circadian clock genes, PER2 and BMAL1. Further, we demonstrated that this estrogen-regulated circuit is necessary for breast epithelial acinar morphogenesis. Disruption of this circuit due to ERA-knockdown, negatively affects the estrogen-sustained circadian PER2-BMAL1 mechanism as well as the formation of 3D HME1 acini. Conversely, knockdown of either PER2 or BMAL1, by hampering the PER2-BMAL1 loop of the circadian clock, negatively affects ERA circadian oscillations and 3D breast acinar morphogenesis. To our knowledge, this study provides the first evidence of the implication of an ERA-circadian clock mechanism in the breast acinar morphogenetic process.

Citing Articles

A time for sex: circadian regulation of mammalian sexual and reproductive function.

Aten S, Ramirez-Plascencia O, Blake C, Holder G, Fishbein E, Vieth A Front Neurosci. 2025; 18():1516767.

PMID: 39834701 PMC: 11743455. DOI: 10.3389/fnins.2024.1516767.


In Vitro Screening of Trehalose Synbiotics and Their Effects on Early-Lactating Females and Offspring Mice.

Peng H, Guo Y, Zhang J, Hei M, Li Y, Zhang W Antioxidants (Basel). 2024; 13(10).

PMID: 39456476 PMC: 11505180. DOI: 10.3390/antiox13101223.


Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.

Li D, Zhou T, Gao J, Wu G, Yang G J Cancer Res Clin Oncol. 2024; 150(9):419.

PMID: 39266868 PMC: 11393214. DOI: 10.1007/s00432-024-05917-w.


The Estrous Cycle Coordinates the Circadian Rhythm of Eating Behavior in Mice.

Alvord V, Pendergast J J Biol Rhythms. 2024; 39(5):413-422.

PMID: 39082411 PMC: 11416336. DOI: 10.1177/07487304241262356.


Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.

Moravcik R, Olejarova S, Zlacka J, Herichova I PLoS One. 2023; 18(10):e0292880.

PMID: 37831728 PMC: 10575541. DOI: 10.1371/journal.pone.0292880.


References
1.
Moriarty K, Kim K, Bender J . Minireview: estrogen receptor-mediated rapid signaling. Endocrinology. 2006; 147(12):5557-63. DOI: 10.1210/en.2006-0729. View

2.
Bjornstrom L, Sjoberg M . Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005; 19(4):833-42. DOI: 10.1210/me.2004-0486. View

3.
Gery S, Virk R, Chumakov K, Yu A, Koeffler H . The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene. 2007; 26(57):7916-20. DOI: 10.1038/sj.onc.1210585. View

4.
Joseph R, Orlov Y, Huss M, Sun W, Kong S, Ukil L . Integrative model of genomic factors for determining binding site selection by estrogen receptor-α. Mol Syst Biol. 2010; 6:456. PMC: 3018168. DOI: 10.1038/msb.2010.109. View

5.
Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z . Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol. 2010; 24(4):709-21. PMC: 2852353. DOI: 10.1210/me.2009-0317. View